Wednesday, September 1, 2010

HL7 Offers Free Webinar on CDA Release 2 and the CCD: Standards for the Meaningful Exchange of Health Information and Clinical Summaries

Health Level Seven® International
For Immediate Release




HL7 Offers Free Ambassador Webinar—CDA Release 2 and the CCD:
Standards for the Meaningful Exchange of Health Information and Clinical Summaries
          Ann Arbor, Michigan, USA – September 1, 2010 – Health Level Seven® International (HL7®), the global authority for interoperability and standards in healthcare information technology with members in 55 countries, will present a complimentary Ambassador webinar on the HL7 Clinical Document Architecture Release 2.0 (CDA) and the Continuity of Care Document (CCD) on Tuesday, September 14 from 11:00 am – 12:00 noon EDT.

The CDA is designed to support the exchange of health information in clinical documentation and the CCD for creating clinical summaries.  These specifications were recently named under the federal regulation in the United States to support meaningful use requirements and have also been selected for use in national and regional programs throughout the world.  This webinar will explain how the CDA and CCD benefit patients and healthcare providers.  It will also assist managers and decision makers involved in the acquisition or development of healthcare IT solutions to understand the business needs met by these HL7 standards.

          Keith W. Boone, standards architect with GE Healthcare, co-chair of the HL7 Structured Documents Work Group, and HL7 ambassador will be presenting the webinar.  Mr. Boone was involved in the development of CDA Release 2.0, and has been an editor of many CDA-based implementation guides developed by organizations including HL7, Integrating the Healthcare Enterprise and ANSI/HITSP, including the HL7 CCD and the ANSI/HITSP C32.

          To register for this free webinar, please visit http://www.hl7.org/events/ambassador092010/. HL7 will also be offering a face-to-face Ambassador session on HL7 and standards for meaningful use at its Annual Plenary and Working Group Meeting being held in Cambridge, MA on October 4, 2010.  For more details, please see http://www.hl7.org/documentcenter/public/pressreleases/HL7_PRESS_20100826.pdf

          HL7 Ambassadors present standardized presentations about HL7 as speaker volunteers. They are available to present at local, regional or national conferences. Please contact HL7 at +1 (734) 677-7777 if you would like to schedule an HL7 Ambassador for an upcoming event.

About Health Level Seven International (HL7)

Founded in 1987, Health Level Seven International is the global authority for healthcare Information interoperability and standards with affiliates established in more than 30 countries. HL7 is a non-profit, ANSI accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7’s more than 2,300 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare. HL7 collaborates with other standards developers and provider, payer, philanthropic and government agencies at the highest levels to ensure the development of comprehensive and reliable standards and successful interoperability efforts.

HL7’s endeavors are sponsored, in part, by the support of its benefactors: Abbott; Accenture; Booz Allen Hamilton; Centers for Disease Control and Prevention; Duke Translational Medicine Institute (DTMI); Eclipsys Corporation; Epic Systems Corporation; European Medicines Agency; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technology; Microsoft Corporation; NHS Connecting for Health; NICTIZ National Healthcare; Novartis Pharmaceuticals Corporation; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; Quest Diagnostics Inc.; Siemens Healthcare; St. Jude Medical; Thomson Reuters; the U.S. Department of Defense, Military Health System; and the U.S. Department of Veterans Affairs.

Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Croatia, Czech Republic, Finland, Germany, Greece, Hong Kong, India, Italy, Japan, Korea, The Netherlands, New Zealand, Norway, Romania, Russia, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, and Uruguay.

For more information, please visit: http://www.hl7.org/



# # #

0 comments:

Post a Comment